Effect of Dietary Glycemic Index on Beta-cell Function

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 1, 2019

Study Completion Date

August 1, 2019

Conditions
Impaired Glucose ToleranceOxidative StressPrediabetesImpaired Fasting Glucose
Interventions
OTHER

low glycemic index (LGI) diet

Following a 2 week medium glycemic index control diet (glycemic index 50-55), subjects will be provided with a weight stable low glycemic index diet (glycemic index \<35) for 4 weeks with all food provided by the Human Nutrition Lab

OTHER

high glycemic index (HGI) diet plus placebo (PLAC)

Following a 2 week medium glycemic index control diet (glycemic index 50-55), subjects will be provided with a weight stable high glycemic index diet (glycemic index \>70) for 4 weeks, all food provided by the Human Nutrition Lab. They will take placebo capsules (matching for active N-acetylcysteine (NAC) in arm 3) twice daily for the 4 weeks on the high GI diet. The NAC vs. placebo arms (arms 2 and 3) will be double-blinded.

DRUG

high glycemic index diet plus N-acetylcysteine

Following a 2 week medium glycemic index control diet (glycemic index 50-55), subjects will be provided with a weight stable high glycemic index diet (glycemic index \>70) for 4 weeks, all food provided by the Human Nutrition Lab. They will take N-acetylcysteine (NAC) two 600 mg capsules twice daily for the 4 weeks on the high GI diet. The NAC vs. placebo arms (arms 2 and 3) will be double-blinded.

Trial Locations (1)

98108

VA Puget Sound Health Care System, Seattle

All Listed Sponsors
collaborator

VA Puget Sound Health Care System

FED

lead

Seattle Institute for Biomedical and Clinical Research

OTHER

NCT01386645 - Effect of Dietary Glycemic Index on Beta-cell Function | Biotech Hunter | Biotech Hunter